Consensus $6.72. The company said, “The company raised its fiscal 2024 guidance range for non-GAAP diluted earnings per share attributable to Cardinal Health, Inc. to $6.75 to $7.00, from $6.50 to $6.75. This guidance includes an update to the company’s Pharmaceutical segment profit outlook for fiscal 2024 to 7% to 9% growth, from 4% to 6% growth. Additionally, the company updated expectations for interest and other to $100 million to $120 million, from $110 million to $130 million, and for diluted weighted average shares outstanding of approximately 249 million, from 250 million to 253 million.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on CAH:
- Options Volatility and Implied Earnings Moves Today, November 03, 2023
- Cardinal Health Reports First Quarter Fiscal 2024 Results and Raises Fiscal 2024 Outlook
- Notable companies reporting before tomorrow’s open
- CAH Upcoming Earnings Report: What to Expect?
- Cardinal Health price target lowered to $95 from $100 at Evercore ISI
Questions or Comments about the article? Write to editor@tipranks.com